Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyBCBSNM epithelial breast cytology Coverage Update …
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - New MexicoPolicy RPLAB024

    Epithelial Cell Cytology in Breast

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - New Mexico Policy RPLAB024 alerts

    Get alerted when Policy RPLAB024 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This reimbursement policy governs coverage and payment for cytologic analysis of epithelial cells from the breast (e.g., nipple aspiration, fine-needle aspiration) and applies to Blue Cross Blue Shield - New Mexico products and participating providers submitting claims to BCBSNM.

    Policy Summary
    PayerBlue Cross Blue Shield - New Mexico
    PolicyEpithelial Cell Cytology in Breast
    Policy CodePolicy RPLAB024
    Change TypeClarified reimbursement stanceminor code additions
    Effective DateSep 4, 2026
    Last ReviewSep 4, 2026
    Next Review Date
    Key ActionSubmit accurate documentation and claims using valid code combinations; claims may be reviewed and may require additional documentation on request.
    SourceLink
    POLICY UPDATE CHANGES

    Edited Reimbursement Information to clarify situations where epithelial cell cytology is not reimbursable and added examples (e.g., nipple aspiration, fine-needle aspiration [FNA]).

    Added CPT codes 88172, 88173, 88177 to the procedure code list.

    not reimbursablestance on cytologic analysis of epithelial breast cells
    88108,88112,88172–88173,88177example procedure codes mentioned
    17references

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    May 15, 2026approval date

    Coverage Criteria

    Non-reimbursable services

    Reimbursement stance

    Cytologic analysis of epithelial cells (e.g., nipple aspiration, fine-needle aspiration [FNA]) to diagnose, to screen for, or to assess risk of developing breast cancer is not reimbursable.

    Covered Indications

    Coding

    Example CPT codes referencedCPT
    88108CYTOPATH CONCENTRATE TECH
    88112CYTOPATH CELL ENHANCE TECH
    88172CYTP DX EVAL FNA 1ST EA SITE
    88173CYTOPATH EVAL FNA REPORT
    88177CYTP FNA EVAL EA ADDL
    Code inclusion note — limitations on list and coverage implication
    Code list scopeThe procedure code list is not all-encompassing; presence of a code in this list does not guarantee the code is a covered service or eligible for reimbursement.
    Example listed codesCPT 88108, 88112, 88172, 88173, 88177 are included as example procedure codes in the policy.
    Source authorityCPT copyright 2025 American Medical Association (AMA).

    Provider Actions & Claims

    Documentation Required

    Documentation and claim submission requirements

    Providers must submit accurate documentation of services performed and file claims using valid code combinations from HIPAA‑approved code sets. Claims are subject to code-edit protocols and review against benefit coverage, provider contract terms, medical and reimbursement policies, and coding software logic; upon request, providers should submit additional documentation.

    • Use industry-standard coding guidelines (e.g., Uniform Billing Editor, AMA CPT, HCPCS, ICD-10-CM/PCS).
    • Submit claims with appropriate code combinations per CMS National Correct Coding Initiative and CCI edits.
    • Respond to requests for additional documentation to support the claim.

    Ordering Requirements

    Note

    Follow Plan documents and provider contracts for ordering

    Plan documents and applicable provider contracts govern coverage determinations; providers should follow those Plan-specific requirements when ordering services.

    • Review member-specific Plan documents (Certificates, Benefit Booklets, Summary Plan Descriptions) for coverage details.
    • Follow provider contract language where it conflicts with the reimbursement policy.

    Definitions

    Epithelial cell cytology — definition and examples
    DefinitionEpithelial cell cytology refers to cytologic analysis of epithelial cells from the breast, for example nipple aspiration cytology and fine-needle aspiration (FNA) cytology.
    Common procedures / techniquesExamples referenced in the policy include nipple aspiration, fine-needle aspiration (FNA), and cytopathology techniques represented by CPT codes such as 88108 (concentrate technique) and 88112 (cell enhance technique).
    Clinical uses notedHistorically used to diagnose, screen for, or assess risk of developing breast cancer; this policy states such uses are not reimbursable.

    Frequency Limits

    Frequency limits
    Specified frequency limitsNone specified in this policy; no frequency rules are provided.
    Plan variationNot all requirements apply to every product; providers should review Plan documents for product-specific coverage and any applicable frequency constraints.
    Ordering implicationBecause no frequency limit is stated, claim adjudication may follow Plan-specific rules and provider contracts.

    Not Covered

    Blue Cross Blue Shield of New Mexico does not reimburse cytologic analysis of epithelial cells from the breast for any of the following purposes: diagnosis, screening, or assessment of cancer risk. This includes specimen-procurement examples such as nipple aspiration and fine-needle aspiration (FNA).

    Policy Summary
    PayerBlue Cross Blue Shield - New Mexico
    PolicyEpithelial Cell Cytology in Breast
    Policy CodePolicy RPLAB024
    Change TypeClarified reimbursement stanceminor code additions
    Effective DateSep 4, 2026
    Last ReviewSep 4, 2026
    Next Review Date
    Key ActionSubmit accurate documentation and claims using valid code combinations; claims may be reviewed and may require additional documentation on request.
    SourceLink
    On This Page
    Coverage CriteriaCovered IndicationsCodingProvider Actions & ClaimsOrdering RequirementsDefinitionsFrequency LimitsNot Covered